ArticleMolecular pharmaceutics2024

Radiation-Activated Cobalamin-Kinase Inhibitors for Treatment of Pancreatic Ductal Adenocarcinoma.

Liberty N Gendron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.